Jeffrey Jones Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

9/2013	Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies.
12/2012	Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey Jones Research Topics

Disease

21	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2020 - 02/2010
12	Neoplasms (Cancer) 01/2021 - 02/2010
4	Pain (Aches) 01/2019 - 07/2015
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 07/2010
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2018
3	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 09/2017
3	Neutropenia 11/2018 - 07/2010
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 11/2013
2	Non-Muscle Invasive Bladder Neoplasms 01/2019 - 01/2019
2	Teratoma (Teratoid Tumor) 12/2018 - 11/2012
2	Diarrhea 11/2018 - 01/2018
2	Hemorrhage 08/2018 - 09/2017
2	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2010
2	Stroke (Strokes) 09/2017 - 12/2002
2	Fatigue 03/2017 - 11/2005
2	Musculoskeletal Pain 10/2016 - 10/2015
2	Wounds and Injuries (Trauma) 07/2015 - 05/2004
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2013 - 12/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2010 - 07/2010
2	Atherosclerosis 12/2002 - 01/2002
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2022
1	Hematuria 05/2022
1	Bone Resorption 01/2022
1	Urolithiasis 01/2022
1	Headache (Headaches) 11/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Abnormal Karyotype 12/2020
1	Vomiting 10/2019
1	Gastroenteritis 10/2019
1	Embryonal Carcinoma 12/2018
1	Seminoma 12/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Anemia 01/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2018
1	Atrial Fibrillation 09/2017
1	Autoimmune Diseases (Autoimmune Disease) 04/2017
1	Cytopenia 03/2017
1	Mental Disorders (Mental Disorder) 01/2016

Drug/Important Bio-Agent (IBA)

5	Lenalidomide (CC 5013)FDA Link 12/2020 - 02/2010
5	ibrutinibIBA 01/2018 - 06/2011
4	5-aminolevulinic acid hexyl ester FDA Link 01/2022 - 01/2018
4	Biological ProductsIBA 10/2016 - 02/2011
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 07/2010
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 07/2010
3	MicroRNAs (MicroRNA)IBA 12/2018 - 10/2015
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018 - 09/2010
3	Rituximab (Mabthera)FDA Link 03/2016 - 10/2013
2	idelalisibIBA 01/2019 - 09/2010
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 02/2011
2	duvelisibIBA 11/2018 - 01/2018
2	Monoclonal AntibodiesIBA 03/2016 - 02/2010
2	Pharmaceutical PreparationsIBA 01/2016 - 03/2012
2	Agammaglobulinaemia Tyrosine KinaseIBA 03/2014 - 06/2011
2	alvocidib (flavopiridol)IBA 10/2013 - 03/2012
2	CytokinesIBA 04/2011 - 02/2011
2	Protein Isoforms (Isoforms)IBA 09/2010 - 01/2002
2	ApolipoproteinsIBA 12/2005 - 12/2002
2	Apolipoproteins AIBA 12/2002 - 01/2002
1	AnticoagulantsIBA 05/2022
1	Warfarin (Coumadin)FDA LinkGeneric 05/2022
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2022
1	CalciumIBA 01/2022
1	Calcium OxalateIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	calcium phosphateIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	cc-486IBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	OxalatesIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	ChemokinesIBA 01/2021
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 12/2020
1	Prochlorperazine (Compazine)FDA LinkGeneric 10/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2018
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 12/2018
1	Transaminases (Aminotransferases)IBA 11/2018
1	Tranexamic Acid (AMCA)FDA Link 08/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017
1	Bortezomib (Velcade)FDA Link 04/2017
1	carfilzomibIBA 04/2017
1	3' Untranslated Regions (3' UTR)IBA 10/2016
1	interleukin-21 (interleukin 21)IBA 01/2016
1	Interleukin-21 ReceptorsIBA 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	Circulating MicroRNAIBA 10/2015
1	Opioid Analgesics (Opioids)IBA 07/2015
1	Opioid Receptors (Opioid Receptor)IBA 07/2015
1	RNA (Ribonucleic Acid)IBA 04/2015

Therapy/Procedure

12	Therapeutics 05/2022 - 02/2010
2	Drug Therapy (Chemotherapy) 11/2013 - 12/2012
2	Space Suits (Space Suit) 11/2005 - 05/2004
1	Catheters 05/2022
1	Sphenopalatine Ganglion Block 11/2021
1	Transurethral Resection of Bladder 01/2019